o2h Chaitime Webinar

Learning the Lessons of Building Grapeshot and Exit to Oracle

AI and Drug Discovery

From PHD to CEO, Entrepreneur War Stories from the Front Line

The Virtualization of Biotechnology to Deliver Superior Investor Returns

Research in Rare Diseases – The Scientists, New Technology and The Patients

Using Knowledge Intensive Investing to Spur the Growth of UK Biotech

Keeping the Technology on the Fast-Track to Transform Healthcare

Next Wave of Britain’s Most Exciting Biotechs- From Small Molecule to Quantum Computing…

The Drug Hunters – Christmas Special

Has the Pandemic been a tailwind for Biotech investing?